Jaramogi Oginga Odinga Teaching and Referral Hospital (JOOTRH)

This new facility will benefit from the expertise of two returning specialists, cardiothoracic and vascular surgeons Dr. Juma Odoro and Dr. Robert Sadia, who have recently completed five years of advanced training in their field.

Victoria Annex already provides apheresis, a specialized treatment that removes and replaces blood components.

Funded by FIND and GARDP, this project evaluates diagnostic capacity for AMR, antibiotic use, and current stewardship practices to inform national health policy and prepare for the introduction of new antibiotics.

This procedure represents a major advancement not only for JOOTRH but also for the entire Lake Region Economic Bloc (LREB), where such specialized surgeries were previously unavailable.

Her focus will be on closing this gap by improving early detection and treatment, as the survival chances for children diagnosed early with cancer are significantly higher than for adults.

This new status aims to attract and retain highly skilled health professionals, which is vital for improving clinical outcomes.

The new treatment is set to transform the management of sickle cell disease (SCD) for many patients in the western region of Kenya, where the condition is highly prevalent.

Before this appointment, Dr. Lesiyampe was the acting CEO at Jaramogi Oginga Odinga Teaching and Referral Hospital (JOOTRH), where he expanded services and enhanced operational capacity.

The introduction of red blood cell exchange (RBCx) therapy marks a significant milestone in the fight against sickle cell disease, impacting many in Kisumu and nearby areas.